Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02610062. IPD Sharing: NO. Countries: 2. Publications: 0.
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06598969. IPD Sharing: NO. Countries: 1. Publications: 0.
Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00005795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06146257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02171117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00049582. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
ClinicalTrials.gov study NCT04049539. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01861314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03737955. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedyspl
ClinicalTrials.gov study NCT03839771. IPD Sharing: NO. Countries: 15. Publications: 0.
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00392353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07255872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06225128. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT
ClinicalTrials.gov study NCT03256071. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation
ClinicalTrials.gov study NCT03881735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
ClinicalTrials.gov study NCT01235572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00093483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02715011. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06990321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05943314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.